Literature DB >> 2015162

Interaction between digoxin and indomethacin or ibuprofen.

H S Jørgensen1, H R Christensen, J P Kampmann.   

Abstract

To study a potential interaction between digoxin and two non-steroid anti-inflammatory drugs, indomethacin (50 mg three times daily) and ibuprofen (600 mg three times daily) were given for 10 days to 10 and 8 patients, respectively, on chronic digoxin treatment. Serum digoxin measured by fluorescence polarisation immunoassay increased significantly (P less than 0.05) during treatment with indomethacin from pre-treatment values of 0.73 +/- 0.34 nmol l-1 (mean +/- s.d.) to a mean value of 1.02 +/- 0.43 nmol l-1, while administration of ibuprofen did not change the steady state serum concentration of digoxin. The result demonstrates that some non-steroidal anti-inflammatory drugs such as indomethacin increase serum digoxin to levels high in the therapeutic range. This should be taken into consideration when co-administering other drugs known to increase the serum concentration of digoxin such as several antiarrhythmics.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2015162      PMCID: PMC1368422          DOI: 10.1111/j.1365-2125.1991.tb03867.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  Serum digoxin concentration: increase after rest in different body positions.

Authors:  M Edner
Journal:  J Cardiovasc Pharmacol       Date:  1990-03       Impact factor: 3.105

2.  Abbott TDx, Dade Stratus, and Du Pont aca automated digoxin immunoassays compared with a reference radioimmunoassay method.

Authors:  D R Clark; R L Inloes; S M Kalman; H H Sussman
Journal:  Clin Chem       Date:  1986-02       Impact factor: 8.327

Review 3.  Clinical pharmacokinetic significance of the renal tubular secretion of digoxin.

Authors:  G Koren
Journal:  Clin Pharmacokinet       Date:  1987-11       Impact factor: 6.447

4.  An interaction study between benoxaprofen and digoxin.

Authors:  B Zöller; H J Engel; G Faust-Tinnefeldt; H E Geissler; H J Gilfrich; M Zimmer
Journal:  Eur J Rheumatol Inflamm       Date:  1982

5.  Toxic digitalis levels associated with indomethacin therapy in a neonate.

Authors:  M S Schimmel; R J Inwood; A I Eidelman; U Eylath
Journal:  Clin Pediatr (Phila)       Date:  1980-11       Impact factor: 1.168

6.  Kinetics of the digoxin-aspirin combination.

Authors:  P E Fenster; K A Comess; C D Hanson; P R Finley
Journal:  Clin Pharmacol Ther       Date:  1982-10       Impact factor: 6.875

7.  Effects of indomethacin on digoxin pharmacokinetics in preterm infants.

Authors:  G Koren; Y Zarfin; M Perlman; S M MacLeod
Journal:  Pediatr Pharmacol (New York)       Date:  1984

8.  [Effect of tiaprofenic acid on serum digoxin concentration].

Authors:  W Doering; J Isbary
Journal:  Arzneimittelforschung       Date:  1983

9.  The effect of ibuprofen on serum digoxin concentrations.

Authors:  F P Quattrocchi; J D Robinson; R W Curry; M L Grieco; S G Schulman
Journal:  Drug Intell Clin Pharm       Date:  1983-04

10.  [Interaction of isoxicam and digoxin].

Authors:  B Zöller; H J Engel; G Faust-Tinnefeldt; H J Gilfrich; M Zimmer
Journal:  Z Rheumatol       Date:  1984 Jul-Aug       Impact factor: 1.372

View more
  8 in total

1.  The effect of meloxicam on the pharmacokinetics of beta-acetyl-digoxin.

Authors:  F L Degner; G Heinzel; H Narjes; D Türck
Journal:  Br J Clin Pharmacol       Date:  1995-11       Impact factor: 4.335

Review 2.  Differential pharmacokinetics of digoxin in elderly patients.

Authors:  C G Hanratty; P McGlinchey; G D Johnston; A P Passmore
Journal:  Drugs Aging       Date:  2000-11       Impact factor: 3.923

Review 3.  Adverse drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs). Recognition, management and avoidance.

Authors:  A G Johnson; P Seideman; R O Day
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

Review 4.  Cardiac glycosides. Drug interactions of clinical significance.

Authors:  B Magnani; P L Malini
Journal:  Drug Saf       Date:  1995-02       Impact factor: 5.606

Review 5.  Pharmacokinetic-pharmacodynamic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  J R Brouwers; P A de Smet
Journal:  Clin Pharmacokinet       Date:  1994-12       Impact factor: 6.447

6.  Nonsteroidal Anti-inflammatory Drugs Utilization Patterns and Risk of Adverse Events due to Drug-Drug Interactions among Elderly Patients: A Study from Jordan.

Authors:  Ahmad Al-Azayzih; Sayer I Al-Azzam; Karem H Alzoubi; Anan S Jarab; Zelal Kharaba; Rami H Al-Rifai; Munther S Alnajjar
Journal:  Saudi Pharm J       Date:  2020-03-20       Impact factor: 4.330

Review 7.  A Comprehensive Review of Non-Steroidal Anti-Inflammatory Drug Use in The Elderly.

Authors:  Supakanya Wongrakpanich; Amaraporn Wongrakpanich; Katie Melhado; Janani Rangaswami
Journal:  Aging Dis       Date:  2018-02-01       Impact factor: 6.745

8.  Predicting the serum digoxin concentrations of infants in the neonatal intensive care unit through an artificial neural network.

Authors:  Shu-Hui Yao; Hsiang-Te Tsai; Wen-Lin Lin; Yu-Chieh Chen; Chiahung Chou; Hsiang-Wen Lin
Journal:  BMC Pediatr       Date:  2019-12-27       Impact factor: 2.125

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.